Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by atrickpayon Aug 13, 2009 12:37pm
280 Views
Post# 16216192

RE: What is wrong with SCT?

RE: What is wrong with SCT?MCA: My hunch is that a bunch of big sellers (ex: somebody from Canaccord sold a fair bit today) are selling this before the Q2 report comes out at the end of this month (sometime in late August according to my email inquiry).  Maybe they bought it a few months back when it was under 10c. And now they want to sell to make sure they lock in their profits.

The bid is at 14c here. I put a limit order in to see if I could get some at this price.
Bullboard Posts